nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethacrynic acid—GSTA2—urine—urinary bladder cancer	0.0468	0.193	CbGeAlD
Ethacrynic acid—ALB—Fluorouracil—urinary bladder cancer	0.0443	0.455	CbGbCtD
Ethacrynic acid—SLC12A1—urine—urinary bladder cancer	0.0425	0.175	CbGeAlD
Ethacrynic acid—SLC22A6—Methotrexate—urinary bladder cancer	0.0287	0.294	CbGbCtD
Ethacrynic acid—ALB—Methotrexate—urinary bladder cancer	0.0244	0.251	CbGbCtD
Ethacrynic acid—GSTA2—Glutathione conjugation—GSTZ1—urinary bladder cancer	0.0201	0.0749	CbGpPWpGaD
Ethacrynic acid—GSTA2—Glutathione conjugation—GSTO2—urinary bladder cancer	0.019	0.071	CbGpPWpGaD
Ethacrynic acid—GSTA2—prostate gland—urinary bladder cancer	0.0168	0.0693	CbGeAlD
Ethacrynic acid—SLC12A1—prostate gland—urinary bladder cancer	0.0153	0.063	CbGeAlD
Ethacrynic acid—GSTA2—epithelium—urinary bladder cancer	0.0123	0.0509	CbGeAlD
Ethacrynic acid—GSTA2—Transcriptional activation by NRF2—NQO1—urinary bladder cancer	0.0123	0.046	CbGpPWpGaD
Ethacrynic acid—GSTA2—renal system—urinary bladder cancer	0.0114	0.0472	CbGeAlD
Ethacrynic acid—SLC12A1—epithelium—urinary bladder cancer	0.0112	0.0463	CbGeAlD
Ethacrynic acid—SLC12A1—renal system—urinary bladder cancer	0.0104	0.0429	CbGeAlD
Ethacrynic acid—SLC12A1—urethra—urinary bladder cancer	0.0102	0.0422	CbGeAlD
Ethacrynic acid—GSTA2—female reproductive system—urinary bladder cancer	0.00917	0.0378	CbGeAlD
Ethacrynic acid—GSTA2—Phase II conjugation—GSTZ1—urinary bladder cancer	0.00893	0.0333	CbGpPWpGaD
Ethacrynic acid—ATP1A1—prostate gland—urinary bladder cancer	0.00889	0.0367	CbGeAlD
Ethacrynic acid—ATP1A1—Preimplantation Embryo—AQP3—urinary bladder cancer	0.00855	0.0319	CbGpPWpGaD
Ethacrynic acid—GSTA2—Phase II conjugation—GSTO2—urinary bladder cancer	0.00847	0.0316	CbGpPWpGaD
Ethacrynic acid—GSTA2—Phase II conjugation—NAT1—urinary bladder cancer	0.00847	0.0316	CbGpPWpGaD
Ethacrynic acid—GSTA2—Glutathione conjugation—HPGDS—urinary bladder cancer	0.00833	0.0311	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Preimplantation Embryo—CDX2—urinary bladder cancer	0.00819	0.0306	CbGpPWpGaD
Ethacrynic acid—GSTA2—Glutathione conjugation—GSTT1—urinary bladder cancer	0.00808	0.0302	CbGpPWpGaD
Ethacrynic acid—GSTA2—Phase II conjugation—UGT2B7—urinary bladder cancer	0.00775	0.0289	CbGpPWpGaD
Ethacrynic acid—GSTA2—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.00765	0.0286	CbGpPWpGaD
Ethacrynic acid—ATP1A1—seminal vesicle—urinary bladder cancer	0.00752	0.031	CbGeAlD
Ethacrynic acid—ATP1A1—epithelium—urinary bladder cancer	0.00653	0.0269	CbGeAlD
Ethacrynic acid—ATP1A1—smooth muscle tissue—urinary bladder cancer	0.00629	0.026	CbGeAlD
Ethacrynic acid—ATP1A1—renal system—urinary bladder cancer	0.00606	0.025	CbGeAlD
Ethacrynic acid—ATP1A1—urethra—urinary bladder cancer	0.00595	0.0245	CbGeAlD
Ethacrynic acid—GSTA2—Glutathione conjugation—GSTP1—urinary bladder cancer	0.0056	0.0209	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—GSTZ1—urinary bladder cancer	0.00523	0.0195	CbGpPWpGaD
Ethacrynic acid—GSTA2—NRF2 pathway—UGT2B7—urinary bladder cancer	0.00517	0.0193	CbGpPWpGaD
Ethacrynic acid—GSTA2—Glutathione conjugation—GSTM1—urinary bladder cancer	0.00515	0.0192	CbGpPWpGaD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—NQO1—urinary bladder cancer	0.00502	0.0188	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—GSTO2—urinary bladder cancer	0.00495	0.0185	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—NAT1—urinary bladder cancer	0.00495	0.0185	CbGpPWpGaD
Ethacrynic acid—ATP1A1—female reproductive system—urinary bladder cancer	0.00485	0.02	CbGeAlD
Ethacrynic acid—GSTA2—Phase II conjugation—NAT2—urinary bladder cancer	0.00464	0.0173	CbGpPWpGaD
Ethacrynic acid—Blood uric acid increased—Thiotepa—urinary bladder cancer	0.00456	0.0116	CcSEcCtD
Ethacrynic acid—GSTA2—Biological oxidations—UGT2B7—urinary bladder cancer	0.00453	0.0169	CbGpPWpGaD
Ethacrynic acid—ATP1A1—vagina—urinary bladder cancer	0.00439	0.0181	CbGeAlD
Ethacrynic acid—GSTA2—Biological oxidations—CYP4B1—urinary bladder cancer	0.00408	0.0152	CbGpPWpGaD
Ethacrynic acid—SLC12A1—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.00392	0.0146	CbGpPWpGaD
Ethacrynic acid—Feeling abnormal—Valrubicin—urinary bladder cancer	0.0038	0.00969	CcSEcCtD
Ethacrynic acid—Hyperuricaemia—Cisplatin—urinary bladder cancer	0.00378	0.00965	CcSEcCtD
Ethacrynic acid—GSTA2—Phase II conjugation—HPGDS—urinary bladder cancer	0.00371	0.0138	CbGpPWpGaD
Ethacrynic acid—Vision blurred—Mitomycin—urinary bladder cancer	0.00367	0.00935	CcSEcCtD
Ethacrynic acid—Pain—Carboplatin—urinary bladder cancer	0.00365	0.00931	CcSEcCtD
Ethacrynic acid—Body temperature increased—Valrubicin—urinary bladder cancer	0.00364	0.00929	CcSEcCtD
Ethacrynic acid—Deafness—Thiotepa—urinary bladder cancer	0.00363	0.00926	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Mitomycin—urinary bladder cancer	0.00361	0.00921	CcSEcCtD
Ethacrynic acid—GSTA2—Phase II conjugation—GSTT1—urinary bladder cancer	0.0036	0.0134	CbGpPWpGaD
Ethacrynic acid—Blood uric acid increased—Cisplatin—urinary bladder cancer	0.00357	0.00912	CcSEcCtD
Ethacrynic acid—Malaise—Mitomycin—urinary bladder cancer	0.00351	0.00895	CcSEcCtD
Ethacrynic acid—Hyperuricaemia—Etoposide—urinary bladder cancer	0.00347	0.00884	CcSEcCtD
Ethacrynic acid—Body temperature increased—Carboplatin—urinary bladder cancer	0.00338	0.00861	CcSEcCtD
Ethacrynic acid—Asthenia—Valrubicin—urinary bladder cancer	0.00331	0.00843	CcSEcCtD
Ethacrynic acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.00328	0.0122	CbGpPWpGaD
Ethacrynic acid—Blood uric acid increased—Etoposide—urinary bladder cancer	0.00327	0.00835	CcSEcCtD
Ethacrynic acid—Discomfort—Mitomycin—urinary bladder cancer	0.00327	0.00835	CcSEcCtD
Ethacrynic acid—Confusional state—Mitomycin—urinary bladder cancer	0.0032	0.00817	CcSEcCtD
Ethacrynic acid—Diarrhoea—Valrubicin—urinary bladder cancer	0.00315	0.00804	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.00311	0.00793	CcSEcCtD
Ethacrynic acid—ATP1A1—Ion channel transport—TRPV1—urinary bladder cancer	0.00306	0.0114	CbGpPWpGaD
Ethacrynic acid—Deafness—Gemcitabine—urinary bladder cancer	0.00306	0.00779	CcSEcCtD
Ethacrynic acid—Anorexia—Mitomycin—urinary bladder cancer	0.00303	0.00772	CcSEcCtD
Ethacrynic acid—ALB—lymph node—urinary bladder cancer	0.00295	0.0122	CbGeAlD
Ethacrynic acid—Vomiting—Valrubicin—urinary bladder cancer	0.00293	0.00747	CcSEcCtD
Ethacrynic acid—Rash—Valrubicin—urinary bladder cancer	0.00291	0.00741	CcSEcCtD
Ethacrynic acid—Dermatitis—Valrubicin—urinary bladder cancer	0.0029	0.00741	CcSEcCtD
Ethacrynic acid—Headache—Valrubicin—urinary bladder cancer	0.00289	0.00736	CcSEcCtD
Ethacrynic acid—Deafness—Cisplatin—urinary bladder cancer	0.00285	0.00726	CcSEcCtD
Ethacrynic acid—ATP1A1—lymph node—urinary bladder cancer	0.00284	0.0117	CbGeAlD
Ethacrynic acid—Decreased appetite—Mitomycin—urinary bladder cancer	0.00276	0.00704	CcSEcCtD
Ethacrynic acid—Nausea—Valrubicin—urinary bladder cancer	0.00274	0.00698	CcSEcCtD
Ethacrynic acid—Fatigue—Mitomycin—urinary bladder cancer	0.00274	0.00698	CcSEcCtD
Ethacrynic acid—Pain—Mitomycin—urinary bladder cancer	0.00272	0.00693	CcSEcCtD
Ethacrynic acid—GSTA2—Biological oxidations—NAT2—urinary bladder cancer	0.00271	0.0101	CbGpPWpGaD
Ethacrynic acid—Gastrointestinal haemorrhage—Fluorouracil—urinary bladder cancer	0.00269	0.00685	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Mitomycin—urinary bladder cancer	0.00262	0.00667	CcSEcCtD
Ethacrynic acid—Gastrointestinal haemorrhage—Cisplatin—urinary bladder cancer	0.00255	0.0065	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Thiotepa—urinary bladder cancer	0.00253	0.00646	CcSEcCtD
Ethacrynic acid—Liver function test abnormal—Gemcitabine—urinary bladder cancer	0.00252	0.00644	CcSEcCtD
Ethacrynic acid—Body temperature increased—Mitomycin—urinary bladder cancer	0.00251	0.0064	CcSEcCtD
Ethacrynic acid—GSTA2—Phase II conjugation—GSTP1—urinary bladder cancer	0.00249	0.00931	CbGpPWpGaD
Ethacrynic acid—Jaundice—Thiotepa—urinary bladder cancer	0.00244	0.00622	CcSEcCtD
Ethacrynic acid—Haematuria—Thiotepa—urinary bladder cancer	0.00239	0.00609	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Thiotepa—urinary bladder cancer	0.00234	0.00596	CcSEcCtD
Ethacrynic acid—Dysphagia—Fluorouracil—urinary bladder cancer	0.00232	0.00592	CcSEcCtD
Ethacrynic acid—GSTA2—Phase II conjugation—GSTM1—urinary bladder cancer	0.00229	0.00855	CbGpPWpGaD
Ethacrynic acid—Asthenia—Mitomycin—urinary bladder cancer	0.00228	0.00581	CcSEcCtD
Ethacrynic acid—Neutropenia—Gemcitabine—urinary bladder cancer	0.00221	0.00563	CcSEcCtD
Ethacrynic acid—ATP1A1—Preimplantation Embryo—CDH1—urinary bladder cancer	0.00219	0.00816	CbGpPWpGaD
Ethacrynic acid—Diarrhoea—Mitomycin—urinary bladder cancer	0.00217	0.00554	CcSEcCtD
Ethacrynic acid—GSTA2—Biological oxidations—HPGDS—urinary bladder cancer	0.00217	0.0081	CbGpPWpGaD
Ethacrynic acid—Hyperglycaemia—Gemcitabine—urinary bladder cancer	0.00213	0.00544	CcSEcCtD
Ethacrynic acid—Abdominal discomfort—Cisplatin—urinary bladder cancer	0.00211	0.00538	CcSEcCtD
Ethacrynic acid—GSTA2—Biological oxidations—GSTT1—urinary bladder cancer	0.0021	0.00786	CbGpPWpGaD
Ethacrynic acid—Tinnitus—Thiotepa—urinary bladder cancer	0.0021	0.00535	CcSEcCtD
Ethacrynic acid—Hyperuricaemia—Methotrexate—urinary bladder cancer	0.00208	0.0053	CcSEcCtD
Ethacrynic acid—Vomiting—Mitomycin—urinary bladder cancer	0.00202	0.00515	CcSEcCtD
Ethacrynic acid—Dysphagia—Etoposide—urinary bladder cancer	0.00202	0.00514	CcSEcCtD
Ethacrynic acid—Chills—Thiotepa—urinary bladder cancer	0.00202	0.00514	CcSEcCtD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.00201	0.00751	CbGpPWpGaD
Ethacrynic acid—Haematuria—Gemcitabine—urinary bladder cancer	0.00201	0.00512	CcSEcCtD
Ethacrynic acid—Rash—Mitomycin—urinary bladder cancer	0.002	0.00511	CcSEcCtD
Ethacrynic acid—Dermatitis—Mitomycin—urinary bladder cancer	0.002	0.0051	CcSEcCtD
Ethacrynic acid—GSTA2—NRF2 pathway—NQO1—urinary bladder cancer	0.00199	0.00744	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00199	0.00743	CbGpPWpGaD
Ethacrynic acid—Headache—Mitomycin—urinary bladder cancer	0.00199	0.00507	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.00197	0.00501	CcSEcCtD
Ethacrynic acid—Blood uric acid increased—Methotrexate—urinary bladder cancer	0.00196	0.005	CcSEcCtD
Ethacrynic acid—Hyperuricaemia—Epirubicin—urinary bladder cancer	0.00194	0.00496	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.00193	0.00493	CcSEcCtD
Ethacrynic acid—Neutropenia—Etoposide—urinary bladder cancer	0.00189	0.00481	CcSEcCtD
Ethacrynic acid—Nausea—Mitomycin—urinary bladder cancer	0.00189	0.00481	CcSEcCtD
Ethacrynic acid—Vision blurred—Thiotepa—urinary bladder cancer	0.00184	0.0047	CcSEcCtD
Ethacrynic acid—Blood uric acid increased—Epirubicin—urinary bladder cancer	0.00184	0.00468	CcSEcCtD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00181	0.00675	CbGpPWpGaD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.00181	0.00674	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—SLC19A1—urinary bladder cancer	0.0018	0.00673	CbGpPWpGaD
Ethacrynic acid—Hyperuricaemia—Doxorubicin—urinary bladder cancer	0.0018	0.00459	CcSEcCtD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.00176	0.00655	CbGpPWpGaD
Ethacrynic acid—Jaundice—Etoposide—urinary bladder cancer	0.00175	0.00447	CcSEcCtD
Ethacrynic acid—Blood uric acid increased—Doxorubicin—urinary bladder cancer	0.0017	0.00433	CcSEcCtD
Ethacrynic acid—Chills—Gemcitabine—urinary bladder cancer	0.0017	0.00433	CcSEcCtD
Ethacrynic acid—Convulsion—Thiotepa—urinary bladder cancer	0.0017	0.00432	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Etoposide—urinary bladder cancer	0.00168	0.00428	CcSEcCtD
Ethacrynic acid—GSTA2—NRF2 pathway—GSTP1—urinary bladder cancer	0.00166	0.00621	CbGpPWpGaD
Ethacrynic acid—Anxiety—Thiotepa—urinary bladder cancer	0.00166	0.00423	CcSEcCtD
Ethacrynic acid—Tinnitus—Cisplatin—urinary bladder cancer	0.00164	0.00419	CcSEcCtD
Ethacrynic acid—Confusional state—Thiotepa—urinary bladder cancer	0.00161	0.00411	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00156	0.00399	CcSEcCtD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.00154	0.00574	CbGpPWpGaD
Ethacrynic acid—GSTA2—NRF2 pathway—GSTM1—urinary bladder cancer	0.00153	0.0057	CbGpPWpGaD
Ethacrynic acid—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.00153	0.0039	CcSEcCtD
Ethacrynic acid—Vision blurred—Fluorouracil—urinary bladder cancer	0.00153	0.00389	CcSEcCtD
Ethacrynic acid—Anorexia—Thiotepa—urinary bladder cancer	0.00152	0.00388	CcSEcCtD
Ethacrynic acid—SLC22A6—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.00149	0.00556	CbGpPWpGaD
Ethacrynic acid—Malaise—Gemcitabine—urinary bladder cancer	0.00148	0.00379	CcSEcCtD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.00147	0.00547	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—GSTP1—urinary bladder cancer	0.00146	0.00544	CbGpPWpGaD
Ethacrynic acid—Chills—Etoposide—urinary bladder cancer	0.00145	0.0037	CcSEcCtD
Ethacrynic acid—Vision blurred—Cisplatin—urinary bladder cancer	0.00145	0.00369	CcSEcCtD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.00144	0.00538	CbGpPWpGaD
Ethacrynic acid—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.00142	0.00363	CcSEcCtD
Ethacrynic acid—Convulsion—Fluorouracil—urinary bladder cancer	0.0014	0.00358	CcSEcCtD
Ethacrynic acid—Decreased appetite—Thiotepa—urinary bladder cancer	0.00139	0.00354	CcSEcCtD
Ethacrynic acid—Discomfort—Gemcitabine—urinary bladder cancer	0.00138	0.00353	CcSEcCtD
Ethacrynic acid—Malaise—Cisplatin—urinary bladder cancer	0.00138	0.00353	CcSEcCtD
Ethacrynic acid—Fatigue—Thiotepa—urinary bladder cancer	0.00138	0.00351	CcSEcCtD
Ethacrynic acid—Pain—Thiotepa—urinary bladder cancer	0.00137	0.00348	CcSEcCtD
Ethacrynic acid—Discomfort—Fluorouracil—urinary bladder cancer	0.00136	0.00347	CcSEcCtD
Ethacrynic acid—Hypoglycaemia—Epirubicin—urinary bladder cancer	0.00134	0.00342	CcSEcCtD
Ethacrynic acid—GSTA2—Biological oxidations—GSTM1—urinary bladder cancer	0.00134	0.005	CbGpPWpGaD
Ethacrynic acid—Confusional state—Fluorouracil—urinary bladder cancer	0.00133	0.0034	CcSEcCtD
Ethacrynic acid—Convulsion—Cisplatin—urinary bladder cancer	0.00133	0.00339	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00132	0.00336	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00132	0.00335	CcSEcCtD
Ethacrynic acid—Gastrointestinal haemorrhage—Epirubicin—urinary bladder cancer	0.00131	0.00334	CcSEcCtD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.00131	0.00488	CbGpPWpGaD
Ethacrynic acid—Ill-defined disorder—Etoposide—urinary bladder cancer	0.0013	0.00333	CcSEcCtD
Ethacrynic acid—Anxiety—Cisplatin—urinary bladder cancer	0.0013	0.00332	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00129	0.0033	CcSEcCtD
Ethacrynic acid—Liver function test abnormal—Methotrexate—urinary bladder cancer	0.00129	0.00329	CcSEcCtD
Ethacrynic acid—Discomfort—Cisplatin—urinary bladder cancer	0.00129	0.00329	CcSEcCtD
Ethacrynic acid—Anorexia—Gemcitabine—urinary bladder cancer	0.00128	0.00327	CcSEcCtD
Ethacrynic acid—ALB—FOXA2 and FOXA3 transcription factor networks—TFRC—urinary bladder cancer	0.00128	0.00476	CbGpPWpGaD
Ethacrynic acid—Malaise—Etoposide—urinary bladder cancer	0.00127	0.00323	CcSEcCtD
Ethacrynic acid—Vertigo—Etoposide—urinary bladder cancer	0.00126	0.00322	CcSEcCtD
Ethacrynic acid—Body temperature increased—Thiotepa—urinary bladder cancer	0.00126	0.00322	CcSEcCtD
Ethacrynic acid—Anorexia—Fluorouracil—urinary bladder cancer	0.00126	0.00321	CcSEcCtD
Ethacrynic acid—Hypoglycaemia—Doxorubicin—urinary bladder cancer	0.00124	0.00316	CcSEcCtD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—MPO—urinary bladder cancer	0.00123	0.0046	CbGpPWpGaD
Ethacrynic acid—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00123	0.00313	CcSEcCtD
Ethacrynic acid—Convulsion—Etoposide—urinary bladder cancer	0.00122	0.00311	CcSEcCtD
Ethacrynic acid—Gastrointestinal haemorrhage—Doxorubicin—urinary bladder cancer	0.00121	0.00309	CcSEcCtD
Ethacrynic acid—Liver function test abnormal—Epirubicin—urinary bladder cancer	0.00121	0.00308	CcSEcCtD
Ethacrynic acid—Anorexia—Cisplatin—urinary bladder cancer	0.00119	0.00304	CcSEcCtD
Ethacrynic acid—Discomfort—Etoposide—urinary bladder cancer	0.00118	0.00302	CcSEcCtD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.00117	0.00438	CbGpPWpGaD
Ethacrynic acid—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00117	0.00298	CcSEcCtD
Ethacrynic acid—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.00116	0.00295	CcSEcCtD
Ethacrynic acid—Fatigue—Gemcitabine—urinary bladder cancer	0.00116	0.00295	CcSEcCtD
Ethacrynic acid—Confusional state—Etoposide—urinary bladder cancer	0.00116	0.00295	CcSEcCtD
Ethacrynic acid—Pain—Gemcitabine—urinary bladder cancer	0.00115	0.00293	CcSEcCtD
Ethacrynic acid—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00115	0.00293	CcSEcCtD
Ethacrynic acid—Asthenia—Thiotepa—urinary bladder cancer	0.00115	0.00292	CcSEcCtD
Ethacrynic acid—Dysphagia—Epirubicin—urinary bladder cancer	0.00113	0.00288	CcSEcCtD
Ethacrynic acid—Neutropenia—Methotrexate—urinary bladder cancer	0.00113	0.00288	CcSEcCtD
Ethacrynic acid—Pain—Fluorouracil—urinary bladder cancer	0.00113	0.00288	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00112	0.00286	CcSEcCtD
Ethacrynic acid—Liver function test abnormal—Doxorubicin—urinary bladder cancer	0.00112	0.00285	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00111	0.00282	CcSEcCtD
Ethacrynic acid—Anorexia—Etoposide—urinary bladder cancer	0.00109	0.00279	CcSEcCtD
Ethacrynic acid—Diarrhoea—Thiotepa—urinary bladder cancer	0.00109	0.00279	CcSEcCtD
Ethacrynic acid—Decreased appetite—Cisplatin—urinary bladder cancer	0.00109	0.00278	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00109	0.00278	CcSEcCtD
Ethacrynic acid—Pain—Cisplatin—urinary bladder cancer	0.00107	0.00273	CcSEcCtD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.00107	0.00398	CbGpPWpGaD
Ethacrynic acid—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00106	0.00271	CcSEcCtD
Ethacrynic acid—Neutropenia—Epirubicin—urinary bladder cancer	0.00106	0.0027	CcSEcCtD
Ethacrynic acid—Dysphagia—Doxorubicin—urinary bladder cancer	0.00105	0.00267	CcSEcCtD
Ethacrynic acid—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00104	0.00266	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00103	0.00263	CcSEcCtD
Ethacrynic acid—Haematuria—Methotrexate—urinary bladder cancer	0.00103	0.00262	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.00102	0.0026	CcSEcCtD
Ethacrynic acid—Vomiting—Thiotepa—urinary bladder cancer	0.00102	0.00259	CcSEcCtD
Ethacrynic acid—Rash—Thiotepa—urinary bladder cancer	0.00101	0.00257	CcSEcCtD
Ethacrynic acid—Dermatitis—Thiotepa—urinary bladder cancer	0.00101	0.00257	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00101	0.00256	CcSEcCtD
Ethacrynic acid—ALB—Folate Metabolism—MPO—urinary bladder cancer	0.001	0.00374	CbGpPWpGaD
Ethacrynic acid—Headache—Thiotepa—urinary bladder cancer	0.001	0.00255	CcSEcCtD
Ethacrynic acid—Decreased appetite—Etoposide—urinary bladder cancer	0.000997	0.00254	CcSEcCtD
Ethacrynic acid—Body temperature increased—Cisplatin—urinary bladder cancer	0.00099	0.00252	CcSEcCtD
Ethacrynic acid—Fatigue—Etoposide—urinary bladder cancer	0.000989	0.00252	CcSEcCtD
Ethacrynic acid—Jaundice—Epirubicin—urinary bladder cancer	0.000983	0.00251	CcSEcCtD
Ethacrynic acid—Pain—Etoposide—urinary bladder cancer	0.000981	0.0025	CcSEcCtD
Ethacrynic acid—Neutropenia—Doxorubicin—urinary bladder cancer	0.000979	0.0025	CcSEcCtD
Ethacrynic acid—Asthenia—Gemcitabine—urinary bladder cancer	0.000964	0.00246	CcSEcCtD
Ethacrynic acid—Haematuria—Epirubicin—urinary bladder cancer	0.000961	0.00245	CcSEcCtD
Ethacrynic acid—Nausea—Thiotepa—urinary bladder cancer	0.000949	0.00242	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Etoposide—urinary bladder cancer	0.000945	0.00241	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000944	0.00241	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000941	0.0024	CcSEcCtD
Ethacrynic acid—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000919	0.00234	CcSEcCtD
Ethacrynic acid—Jaundice—Doxorubicin—urinary bladder cancer	0.000909	0.00232	CcSEcCtD
Ethacrynic acid—Body temperature increased—Etoposide—urinary bladder cancer	0.000907	0.00231	CcSEcCtD
Ethacrynic acid—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000904	0.0023	CcSEcCtD
Ethacrynic acid—Tinnitus—Methotrexate—urinary bladder cancer	0.000902	0.0023	CcSEcCtD
Ethacrynic acid—Asthenia—Cisplatin—urinary bladder cancer	0.000899	0.00229	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—GSTZ1—urinary bladder cancer	0.000894	0.00334	CbGpPWpGaD
Ethacrynic acid—Haematuria—Doxorubicin—urinary bladder cancer	0.00089	0.00227	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000871	0.00222	CcSEcCtD
Ethacrynic acid—Chills—Methotrexate—urinary bladder cancer	0.000868	0.00221	CcSEcCtD
Ethacrynic acid—Diarrhoea—Cisplatin—urinary bladder cancer	0.000857	0.00219	CcSEcCtD
Ethacrynic acid—Vomiting—Gemcitabine—urinary bladder cancer	0.000854	0.00218	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—GSTO2—urinary bladder cancer	0.000847	0.00316	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—NAT1—urinary bladder cancer	0.000847	0.00316	CbGpPWpGaD
Ethacrynic acid—Rash—Gemcitabine—urinary bladder cancer	0.000847	0.00216	CcSEcCtD
Ethacrynic acid—Dermatitis—Gemcitabine—urinary bladder cancer	0.000846	0.00216	CcSEcCtD
Ethacrynic acid—Tinnitus—Epirubicin—urinary bladder cancer	0.000844	0.00215	CcSEcCtD
Ethacrynic acid—Headache—Gemcitabine—urinary bladder cancer	0.000842	0.00215	CcSEcCtD
Ethacrynic acid—Vomiting—Fluorouracil—urinary bladder cancer	0.00084	0.00214	CcSEcCtD
Ethacrynic acid—Rash—Fluorouracil—urinary bladder cancer	0.000833	0.00212	CcSEcCtD
Ethacrynic acid—Dermatitis—Fluorouracil—urinary bladder cancer	0.000832	0.00212	CcSEcCtD
Ethacrynic acid—Headache—Fluorouracil—urinary bladder cancer	0.000828	0.00211	CcSEcCtD
Ethacrynic acid—Asthenia—Etoposide—urinary bladder cancer	0.000823	0.0021	CcSEcCtD
Ethacrynic acid—Chills—Epirubicin—urinary bladder cancer	0.000812	0.00207	CcSEcCtD
Ethacrynic acid—Nausea—Gemcitabine—urinary bladder cancer	0.000798	0.00204	CcSEcCtD
Ethacrynic acid—ALB—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.000796	0.00297	CbGpPWpGaD
Ethacrynic acid—Vomiting—Cisplatin—urinary bladder cancer	0.000796	0.00203	CcSEcCtD
Ethacrynic acid—Vision blurred—Methotrexate—urinary bladder cancer	0.000794	0.00202	CcSEcCtD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000793	0.00296	CbGpPWpGaD
Ethacrynic acid—Rash—Cisplatin—urinary bladder cancer	0.00079	0.00201	CcSEcCtD
Ethacrynic acid—Dermatitis—Cisplatin—urinary bladder cancer	0.000789	0.00201	CcSEcCtD
Ethacrynic acid—Diarrhoea—Etoposide—urinary bladder cancer	0.000785	0.002	CcSEcCtD
Ethacrynic acid—Nausea—Fluorouracil—urinary bladder cancer	0.000785	0.002	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000781	0.00199	CcSEcCtD
Ethacrynic acid—Tinnitus—Doxorubicin—urinary bladder cancer	0.000781	0.00199	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—UGT2B7—urinary bladder cancer	0.000775	0.00289	CbGpPWpGaD
Ethacrynic acid—ALB—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000774	0.00289	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—SOD2—urinary bladder cancer	0.000774	0.00289	CbGpPWpGaD
Ethacrynic acid—Malaise—Methotrexate—urinary bladder cancer	0.000759	0.00194	CcSEcCtD
Ethacrynic acid—Vertigo—Methotrexate—urinary bladder cancer	0.000757	0.00193	CcSEcCtD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000757	0.00282	CbGpPWpGaD
Ethacrynic acid—Chills—Doxorubicin—urinary bladder cancer	0.000752	0.00192	CcSEcCtD
Ethacrynic acid—Nausea—Cisplatin—urinary bladder cancer	0.000744	0.0019	CcSEcCtD
Ethacrynic acid—Vision blurred—Epirubicin—urinary bladder cancer	0.000743	0.00189	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000731	0.00186	CcSEcCtD
Ethacrynic acid—Convulsion—Methotrexate—urinary bladder cancer	0.00073	0.00186	CcSEcCtD
Ethacrynic acid—Vomiting—Etoposide—urinary bladder cancer	0.000729	0.00186	CcSEcCtD
Ethacrynic acid—Rash—Etoposide—urinary bladder cancer	0.000723	0.00184	CcSEcCtD
Ethacrynic acid—Dermatitis—Etoposide—urinary bladder cancer	0.000723	0.00184	CcSEcCtD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.00072	0.00269	CbGpPWpGaD
Ethacrynic acid—Headache—Etoposide—urinary bladder cancer	0.000719	0.00183	CcSEcCtD
Ethacrynic acid—Malaise—Epirubicin—urinary bladder cancer	0.000711	0.00181	CcSEcCtD
Ethacrynic acid—Discomfort—Methotrexate—urinary bladder cancer	0.000708	0.00181	CcSEcCtD
Ethacrynic acid—Vertigo—Epirubicin—urinary bladder cancer	0.000708	0.00181	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—CYP4B1—urinary bladder cancer	0.000698	0.0026	CbGpPWpGaD
Ethacrynic acid—Confusional state—Methotrexate—urinary bladder cancer	0.000693	0.00177	CcSEcCtD
Ethacrynic acid—Vision blurred—Doxorubicin—urinary bladder cancer	0.000687	0.00175	CcSEcCtD
Ethacrynic acid—Convulsion—Epirubicin—urinary bladder cancer	0.000683	0.00174	CcSEcCtD
Ethacrynic acid—Nausea—Etoposide—urinary bladder cancer	0.000682	0.00174	CcSEcCtD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—MTHFR—urinary bladder cancer	0.000681	0.00254	CbGpPWpGaD
Ethacrynic acid—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000677	0.00173	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000673	0.00172	CcSEcCtD
Ethacrynic acid—Anxiety—Epirubicin—urinary bladder cancer	0.000669	0.0017	CcSEcCtD
Ethacrynic acid—Discomfort—Epirubicin—urinary bladder cancer	0.000663	0.00169	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—SLC19A1—urinary bladder cancer	0.000659	0.00246	CbGpPWpGaD
Ethacrynic acid—Malaise—Doxorubicin—urinary bladder cancer	0.000658	0.00168	CcSEcCtD
Ethacrynic acid—Vertigo—Doxorubicin—urinary bladder cancer	0.000655	0.00167	CcSEcCtD
Ethacrynic acid—Anorexia—Methotrexate—urinary bladder cancer	0.000655	0.00167	CcSEcCtD
Ethacrynic acid—Confusional state—Epirubicin—urinary bladder cancer	0.000648	0.00165	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—PRSS3—urinary bladder cancer	0.000642	0.0024	CbGpPWpGaD
Ethacrynic acid—Convulsion—Doxorubicin—urinary bladder cancer	0.000632	0.00161	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.00063	0.00161	CcSEcCtD
Ethacrynic acid—ALB—Folate Metabolism—SOD2—urinary bladder cancer	0.00063	0.00235	CbGpPWpGaD
Ethacrynic acid—Anxiety—Doxorubicin—urinary bladder cancer	0.000619	0.00158	CcSEcCtD
Ethacrynic acid—Discomfort—Doxorubicin—urinary bladder cancer	0.000613	0.00156	CcSEcCtD
Ethacrynic acid—Anorexia—Epirubicin—urinary bladder cancer	0.000613	0.00156	CcSEcCtD
Ethacrynic acid—ALB—Folate Metabolism—GPX1—urinary bladder cancer	0.000601	0.00224	CbGpPWpGaD
Ethacrynic acid—Confusional state—Doxorubicin—urinary bladder cancer	0.0006	0.00153	CcSEcCtD
Ethacrynic acid—Decreased appetite—Methotrexate—urinary bladder cancer	0.000597	0.00152	CcSEcCtD
Ethacrynic acid—Fatigue—Methotrexate—urinary bladder cancer	0.000593	0.00151	CcSEcCtD
Ethacrynic acid—Pain—Methotrexate—urinary bladder cancer	0.000588	0.0015	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000583	0.00149	CcSEcCtD
Ethacrynic acid—Anorexia—Doxorubicin—urinary bladder cancer	0.000567	0.00145	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000566	0.00144	CcSEcCtD
Ethacrynic acid—Decreased appetite—Epirubicin—urinary bladder cancer	0.000559	0.00143	CcSEcCtD
Ethacrynic acid—Fatigue—Epirubicin—urinary bladder cancer	0.000554	0.00141	CcSEcCtD
Ethacrynic acid—ALB—Folate Metabolism—MTHFR—urinary bladder cancer	0.000554	0.00207	CbGpPWpGaD
Ethacrynic acid—Pain—Epirubicin—urinary bladder cancer	0.00055	0.0014	CcSEcCtD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000547	0.00204	CbGpPWpGaD
Ethacrynic acid—Body temperature increased—Methotrexate—urinary bladder cancer	0.000543	0.00139	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00053	0.00135	CcSEcCtD
Ethacrynic acid—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000517	0.00132	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—TYMP—urinary bladder cancer	0.000513	0.00192	CbGpPWpGaD
Ethacrynic acid—Fatigue—Doxorubicin—urinary bladder cancer	0.000513	0.00131	CcSEcCtD
Ethacrynic acid—Pain—Doxorubicin—urinary bladder cancer	0.000509	0.0013	CcSEcCtD
Ethacrynic acid—Body temperature increased—Epirubicin—urinary bladder cancer	0.000508	0.0013	CcSEcCtD
Ethacrynic acid—ALB—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.0005	0.00187	CbGpPWpGaD
Ethacrynic acid—Asthenia—Methotrexate—urinary bladder cancer	0.000493	0.00126	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00049	0.00125	CcSEcCtD
Ethacrynic acid—ALB—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000477	0.00178	CbGpPWpGaD
Ethacrynic acid—Body temperature increased—Doxorubicin—urinary bladder cancer	0.00047	0.0012	CcSEcCtD
Ethacrynic acid—Diarrhoea—Methotrexate—urinary bladder cancer	0.00047	0.0012	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—NAT2—urinary bladder cancer	0.000464	0.00173	CbGpPWpGaD
Ethacrynic acid—Asthenia—Epirubicin—urinary bladder cancer	0.000461	0.00118	CcSEcCtD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000446	0.00166	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.00044	0.00164	CbGpPWpGaD
Ethacrynic acid—Diarrhoea—Epirubicin—urinary bladder cancer	0.00044	0.00112	CcSEcCtD
Ethacrynic acid—Vomiting—Methotrexate—urinary bladder cancer	0.000437	0.00111	CcSEcCtD
Ethacrynic acid—Rash—Methotrexate—urinary bladder cancer	0.000433	0.0011	CcSEcCtD
Ethacrynic acid—Dermatitis—Methotrexate—urinary bladder cancer	0.000433	0.0011	CcSEcCtD
Ethacrynic acid—Headache—Methotrexate—urinary bladder cancer	0.000431	0.0011	CcSEcCtD
Ethacrynic acid—Asthenia—Doxorubicin—urinary bladder cancer	0.000427	0.00109	CcSEcCtD
Ethacrynic acid—Vomiting—Epirubicin—urinary bladder cancer	0.000409	0.00104	CcSEcCtD
Ethacrynic acid—Nausea—Methotrexate—urinary bladder cancer	0.000408	0.00104	CcSEcCtD
Ethacrynic acid—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000407	0.00104	CcSEcCtD
Ethacrynic acid—Rash—Epirubicin—urinary bladder cancer	0.000406	0.00103	CcSEcCtD
Ethacrynic acid—Dermatitis—Epirubicin—urinary bladder cancer	0.000405	0.00103	CcSEcCtD
Ethacrynic acid—Headache—Epirubicin—urinary bladder cancer	0.000403	0.00103	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—RRM2—urinary bladder cancer	0.000401	0.0015	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000393	0.00147	CbGpPWpGaD
Ethacrynic acid—Nausea—Epirubicin—urinary bladder cancer	0.000382	0.000974	CcSEcCtD
Ethacrynic acid—Vomiting—Doxorubicin—urinary bladder cancer	0.000378	0.000965	CcSEcCtD
Ethacrynic acid—Rash—Doxorubicin—urinary bladder cancer	0.000375	0.000957	CcSEcCtD
Ethacrynic acid—Dermatitis—Doxorubicin—urinary bladder cancer	0.000375	0.000956	CcSEcCtD
Ethacrynic acid—Headache—Doxorubicin—urinary bladder cancer	0.000373	0.000951	CcSEcCtD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000371	0.00139	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—HPGDS—urinary bladder cancer	0.000371	0.00139	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ENO2—urinary bladder cancer	0.000371	0.00139	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet degranulation—IGF1—urinary bladder cancer	0.000366	0.00136	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GSTT1—urinary bladder cancer	0.00036	0.00134	CbGpPWpGaD
Ethacrynic acid—Nausea—Doxorubicin—urinary bladder cancer	0.000353	0.000901	CcSEcCtD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—urinary bladder cancer	0.000348	0.0013	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000341	0.00127	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000337	0.00126	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—IL2—urinary bladder cancer	0.000328	0.00122	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000301	0.00112	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—NQO1—urinary bladder cancer	0.000299	0.00112	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—TNF—urinary bladder cancer	0.000293	0.00109	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000284	0.00106	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.000281	0.00105	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GSTP1—urinary bladder cancer	0.000249	0.000931	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—TNF—urinary bladder cancer	0.000239	0.000891	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—TYMS—urinary bladder cancer	0.000232	0.000866	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000232	0.000865	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—NCOR1—urinary bladder cancer	0.000229	0.000856	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GSTM1—urinary bladder cancer	0.000229	0.000856	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GPX1—urinary bladder cancer	0.00022	0.000819	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ERCC2—urinary bladder cancer	0.000216	0.000805	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—TP53—urinary bladder cancer	0.00021	0.000785	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—MTHFR—urinary bladder cancer	0.000203	0.000756	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTZ1—urinary bladder cancer	0.000194	0.000725	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—TNF—urinary bladder cancer	0.00019	0.000708	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTO2—urinary bladder cancer	0.000184	0.000687	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NAT1—urinary bladder cancer	0.000184	0.000687	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000181	0.000676	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—UGT2B7—urinary bladder cancer	0.000168	0.000629	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PPARG—urinary bladder cancer	0.000164	0.000613	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	0.000162	0.000605	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CREBBP—urinary bladder cancer	0.000158	0.000589	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000157	0.000584	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP4B1—urinary bladder cancer	0.000152	0.000566	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	0.000149	0.000554	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IFNA2—urinary bladder cancer	0.000145	0.00054	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SLC19A1—urinary bladder cancer	0.000143	0.000535	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000141	0.000526	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PRSS3—urinary bladder cancer	0.00014	0.000521	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PTGS2—urinary bladder cancer	0.000129	0.000482	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	0.000125	0.000465	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PTEN—urinary bladder cancer	0.000113	0.000421	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000112	0.000418	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—TYMP—urinary bladder cancer	0.000112	0.000416	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	0.000109	0.000406	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—EP300—urinary bladder cancer	0.000107	0.000401	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000107	0.0004	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PLAU—urinary bladder cancer	0.000103	0.000383	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NAT2—urinary bladder cancer	0.000101	0.000377	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—RRM2—urinary bladder cancer	8.71e-05	0.000325	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—CREBBP—urinary bladder cancer	8.46e-05	0.000316	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IGF1—urinary bladder cancer	8.36e-05	0.000312	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ENO2—urinary bladder cancer	8.07e-05	0.000301	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HPGDS—urinary bladder cancer	8.07e-05	0.000301	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	8.02e-05	0.000299	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTT1—urinary bladder cancer	7.83e-05	0.000292	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	7.71e-05	0.000288	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—RHOA—urinary bladder cancer	7.66e-05	0.000286	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.33e-05	0.000273	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NQO1—urinary bladder cancer	6.5e-05	0.000243	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IL2—urinary bladder cancer	6.42e-05	0.00024	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.31e-05	0.000235	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—EP300—urinary bladder cancer	5.76e-05	0.000215	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—SRC—urinary bladder cancer	5.61e-05	0.000209	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.5e-05	0.000205	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTP1—urinary bladder cancer	5.42e-05	0.000202	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.25e-05	0.000196	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—TYMS—urinary bladder cancer	5.04e-05	0.000188	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NCOR1—urinary bladder cancer	4.98e-05	0.000186	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTM1—urinary bladder cancer	4.98e-05	0.000186	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GPX1—urinary bladder cancer	4.77e-05	0.000178	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ERCC2—urinary bladder cancer	4.69e-05	0.000175	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—KRAS—urinary bladder cancer	4.64e-05	0.000173	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—MTHFR—urinary bladder cancer	4.41e-05	0.000164	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—TP53—urinary bladder cancer	4.12e-05	0.000154	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—HRAS—urinary bladder cancer	3.94e-05	0.000147	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PPARG—urinary bladder cancer	3.57e-05	0.000133	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CREBBP—urinary bladder cancer	3.43e-05	0.000128	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PTGS2—urinary bladder cancer	2.81e-05	0.000105	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PTEN—urinary bladder cancer	2.45e-05	9.15e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—EP300—urinary bladder cancer	2.34e-05	8.72e-05	CbGpPWpGaD
